Amer Bio Medica
American Bio Medica Corporation engages in manufacture and sale of lateral flow immunoassay tests primarily for the immediate detection of drugs in urine and oral fluids. Its drugs detection products in urine include Rapid Drug Screen, a rapid drug test, which detects the presence or absence of 2 to 10 drugs; RDS InCup, a drug-testing cup that detects the presence or absence of 1 to 12 drugs; Rap… Read more
Amer Bio Medica (ABMC) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of March 2023: 0.793x
Based on the latest financial reports, Amer Bio Medica (ABMC) has a cash flow conversion efficiency ratio of 0.793x as of March 2023.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-363.00K) by net assets ($-458.00K). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Amer Bio Medica - Cash Flow Conversion Efficiency Trend (1996–2022)
This chart illustrates how Amer Bio Medica's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Amer Bio Medica Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Amer Bio Medica ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Empresa Regional de Servicio Publico de Electricidad Electronorte Medio S.A.-Hidrandina
LIM:HIDRA2C1
|
N/A |
|
Fubon No.1 Real Estate Investment Trust
TW:01001T
|
N/A |
|
Abadi Lestari Indonesia Tbk
JK:RLCO
|
N/A |
|
CDL INVESTMENT
BE:BXU
|
N/A |
|
Medical Intl Tech
OTCGREY:MDLH
|
2.409x |
|
Toucan Interactive Corp
PINK:TCNT
|
0.052x |
|
Galaxy Cosmos Mezz PLC
AT:GCMEZZ
|
N/A |
|
Minehub Technologies Inc
OTCQB:MHUBF
|
-1.632x |
Annual Cash Flow Conversion Efficiency for Amer Bio Medica (1996–2022)
The table below shows the annual cash flow conversion efficiency of Amer Bio Medica from 1996 to 2022.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2022-12-31 | $-2.34 Million | $-768.00K | 0.328x | -53.94% |
| 2021-12-31 | $-944.00K | $-673.00K | 0.713x | +85.39% |
| 2020-12-31 | $-1.26 Million | $-483.00K | 0.385x | +623.79% |
| 2019-12-31 | $-790.00K | $58.00K | -0.073x | -104.87% |
| 2018-12-31 | $-146.00K | $-220.00K | 1.507x | +418.66% |
| 2017-12-31 | $623.00K | $181.00K | 0.291x | +23.57% |
| 2016-12-31 | $1.02 Million | $241.00K | 0.235x | -1.76% |
| 2015-12-31 | $961.00K | $230.00K | 0.239x | +136.89% |
| 2014-12-31 | $970.00K | $98.00K | 0.101x | +1401.99% |
| 2013-12-31 | $1.34 Million | $9.00K | 0.007x | -96.11% |
| 2012-12-31 | $1.36 Million | $236.00K | 0.173x | -8.67% |
| 2011-12-31 | $2.37 Million | $449.00K | 0.189x | +1049.76% |
| 2010-12-31 | $2.66 Million | $-53.00K | -0.020x | -126.53% |
| 2009-12-31 | $3.38 Million | $254.00K | 0.075x | +205.67% |
| 2008-12-31 | $4.26 Million | $-303.00K | -0.071x | +40.06% |
| 2007-12-31 | $5.10 Million | $-605.00K | -0.119x | -309.57% |
| 2006-12-31 | $6.04 Million | $342.00K | 0.057x | +184.56% |
| 2005-12-31 | $5.55 Million | $-372.00K | -0.067x | -391.86% |
| 2004-12-31 | $5.84 Million | $134.00K | 0.023x | -84.02% |
| 2003-12-31 | $4.76 Million | $684.00K | 0.144x | +219.22% |
| 2002-12-31 | $3.32 Million | $-400.00K | -0.120x | +69.19% |
| 2001-12-31 | $2.35 Million | $-920.00K | -0.391x | -48.40% |
| 2000-12-31 | $3.21 Million | $-846.00K | -0.263x | +60.99% |
| 1999-12-31 | $2.97 Million | $-2.01 Million | -0.675x | -27.29% |
| 1998-12-31 | $4.90 Million | $-2.60 Million | -0.531x | -58.81% |
| 1997-12-31 | $3.73 Million | $-1.25 Million | -0.334x | 0.00% |
| 1996-12-31 | $3.73 Million | $-1.25 Million | -0.334x | -- |